Purpose. To review the surgical treatment for metastatic disease of the proximal femur. Methods. Records of 8 patients who underwent endoprosthetic replacement with tumour resection (group 1) and 8 others who underwent intramedullary nailing without tumour resection (group 2) were reviewed. Treatments were based on the disease progression and patient's condition. Results. In groups 1 and 2, the respective mean survival periods were 16 and 4 months. All patients in group 1 regained preoperative mobility, but only one patient in group 2 was able to walk with crutches. Conclusion. This was a retrospective, rather than comparative study of endoprothetic replacement and intramedullary nailing for metastatic disease of the proximal femur. Both procedures are considered palliative, and not curative. The longer survival period in group 1 was mainly due to selection of Journal of Orthopaedic Surgery 2007;15(3):295-8 patients with better preoperative medical status.
INTRODUCTION
The proximal femur is the most common long bone site subject to metastatic disease and/or actual or impending pathological fractures. The treatment goals are pain relief and restoration of ambulatory function. Surgical management is based on the location, type, and extent of tumour, and patient's general condition. 1 Surgery should be aggressive (such as endoprosthetic replacement or internal fixation and augmentation with methylmethacryate, together with tumour resection) when the chance of recovery is high. Patients who are in a poor condition or considered unlikely to recover may be more suitable for palliative treatment (such as intramedullary nailing or external fixation without tumour resection), despite being restricted to bed and chair after surgery. 1 We report outcomes of 16 patients with metastatic lesions of the proximal femur and discuss the advantages and shortcomings of 2 surgical methods.
MATERIALS AND METHODS
Between 1993 and 2002, records of 8 patients aged 37 to 72 (mean, 54) years who underwent endoprosthetic replacement with tumour resection (group 1, Fig.  1 ) and 8 others aged 64 to 76 (mean, 70) years who underwent intramedullary nailing without tumour resection (group 2, Fig. 2 ) were reviewed. All patients were able to walk before their fracture and received adjuvant chemotherapy, radiotherapy, and/or hormonal therapy before surgery. The indication for surgery was actual or impending pathologic fracture. The prerequisites for surgery were fitness for anaesthesia and having a predicted survival of 2 to 4 weeks. Patient selection was based on the prognosis (disease progress, patient's age, and general condition).
In group 1, patients were expected to survive for more than a few months. The surgery involved subfascial resection of the tumour and joint capsule, while the muscles around the hip joint were preserved. The greater trochanter with both gluteus medius and vastus lateralis and the femur were osteotomised at least 2 cm beyond the margin of tumour. For impending fractures, an extralesional resection was performed. In actual fractures, in most instances, intralesional resection (without resecting the muscles in the compartment) was performed. A tumour endoprosthesis (Howmedica Modular Resection System; Stryker Howmedica Osteonics, Allendale [NJ], US) was inserted. The external rotators and the psoas were sutured tightly around the prosthesis neck, forming a noose that provided immediate stability. The remaining fragment of the greater trochanter was fixed to the prosthesis with the plate-screw system. This enabled walking with full weight bearing for the expected survival period.
In group 2, patients were not expected to recover and did not want to commit time and expenses. They underwent intramedullary nailing (Gamma nail) without tumour resection to improve pain and avoid being bedridden.
RESULTS
In groups 1 and 2 respectively, patients were followed up for a mean of 27 (range, 11-87) and 11 (range, 2-37) months (Table) . Respective mean operating times were 195 (range, 130-282) and 113 (range, 66-180) minutes, intra-operative blood losses were 858 (range, 410-1700) and 243 (range, 0-700) g, postoperative decreases in haemoglobin levels were 2.3 (range, 0.5-4.3) and 3.5 (range, 1-5.9) g/ml, and peri-operative units of blood transfused were 1.75 (range, 0-8) and 2.63 (range, 0-14).
In group 1, functional results were satisfactory; 5 were able to walk independently, 3 using a stick or crutches. In group 2, only one patient was able to walk with crutches. The respective mean survival periods were 16 (range, 9-31) and 4 (range, 2-7) months, and the respective one-year survival rates were 69 and 13%. Serious complications, including deep infection, dislocation, displacement, and breakage of the endoprosthesis or nail implant, were not encountered. Most patients in each group achieved the goal of their surgical methods.
DISCUSSION
Proximal femur-replacing prostheses result in loss of hip flexor and abductor strength and permanent gait disturbance, 1 despite yielding good functional results. [2] [3] [4] [5] Double plate osteosynthesis combined with polymethylmethacrylate has been recommended, 6 but is highly invasive and difficult.
In group 1, normal distal bone was adequately resected (even in intralesional resection) and muscles around the hip joint were preserved as much as possible. This treatment is safer, because the risk of hip dislocation decreases as the hip joint is reconstructed with preserved muscles and blood loss is minimised by subfascial resection without substantial exposure of the tumour.
In group 2 the functional results were poor. Nonetheless, good outcomes (walking with crutches or a frame) have been reported in 24 of 30 patients who underwent unreamed intamedullary nailing for pathologic femoral fracture. 7 However, healing of pathologic fractures is impeded by both the metastatic tumour and radiotherapy, with a union rate of 35%. 8
Patient
No. In group 2, intramedullary nailing was not sufficient to stabilise pathologic fractures of the proximal femur to enable full weight bearing, and was associated with a low union rate and high risk of recurrence and metastasis. It was only used to facilitate nursing care and avoid being bedridden. We used the thickest nails possible in order to attain rigid stabilisation. Nonetheless, reaming increased postoperative blood loss, even in carefully performed closed reduction and internal fixation without exposure of the focus.
Sex/age (years) Primary tumour Secondary location Metastatsis
Complete pathologic fracture should be stabilised immediately, even if the patient's condition is poor and/or the expected survival period is short. The anticipated period of survival was determined by the nature of the primary tumour, rather than the surgery performed. Patients should undergo surgery if the expected period of survival exceeds the recovery time. Even experienced oncologists cannot accurately estimate the survival period; some patients in group 2 survived longer than predicted. Therefore, the choice of surgical method should be based more on preoperative activities of daily living than on the tumour type or estimated survival period.
This was a retrospective, rather than comparative study of endoprothetic replacement and intramedullary nailing for metastatic disease of the proximal femur. Both procedures are considered palliative, rather than curative. The longer survival period in group 1 was mainly due to selection of patients with better preoperative medical conditions.
